IPAD-DB ID | S00828 |
Name | R(-)-Norapomorphine hydrobromide |
Category | Synthetic compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C 1 6 H 1 6 B r N O 2 |
Molecular Weight | 334.21 g/mol |
IUPAC Name | 5, 6, 6a, 7-tetrahydro-4H-dibenzo[de, g]quinoline-10, 11-diol;hydrobromide |
InChI | InChI=1S/C16H15NO2.BrH/c18-13-5-4-10-8-12-14-9(6-7-17-12)2-1-3-11(14)15(10)16(13)19;/h1-5, 12, 17-19H, 6-8H2;1H |
InChIKey | SKTWZBLODKWJOU-UHFFFAOYSA-N |
Canonical SMILES | C1CNC2CC3=C(C4=CC=CC1=C24)C(=C(C=C3)O)O.Br |
PubChem CID | 163304539 |
DrugBank Accession Number | - |
CAS Registry Number | - |
Molecular Weight(Computed by SwissADME) | 334.21 |
Hac(Computed by SwissADME) | 20 |
Volume(Computed by ADMETlab 2.0) | 263.825 |
Density(Computed by ADMETlab 2.0) | 0.959 |
nRing(Computed by ADMETlab 2.0) | 4 |
MaxRing(Computed by ADMETlab 2.0) | 16 |
nHet(Computed by ADMETlab 2.0) | 3 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 20 |
Flexibility(Computed by ADMETlab 2.0) | 0 |
Stero Centers(Computed by ADMETlab 2.0) | 1 |
LogS(Computed by ADMETlab 2.0) | -1.96 |
LogD(Computed by ADMETlab 2.0) | 1.993 |
logP(Computed by ADMETlab 2.0) | 1.99 |
TPSA(Computed by SwissADME) | 52.49 |
Hbond Acceptor(Computed by SwissADME) | 3 |
Hbond Donor(Computed by SwissADME) | 3 |
Rotatable Bonds(Computed by SwissADME) | 0 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | Yes |
P-gp Substrate(Computed by SwissADME) | Yes |
CYP1A2 Inhibitor(Computed by SwissADME) | Yes |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | No |
CYP2D6 Inhibitor(Computed by SwissADME) | Yes |
CYP3A4 Inhibitor(Computed by SwissADME) | Yes |
log Kp(Skin Permeation)(Computed by SwissADME) | -6.35 |
Lipinski(Computed by SwissADME) | 0 |
Ghose(Computed by SwissADME) | 0 |
Veber(Computed by SwissADME) | 0 |
Egan(Computed by SwissADME) | 0 |
Muegge(Computed by SwissADME) | 0 |
Bioavailability Score(Computed by SwissADME) | 0.55 |